Thromboelastography during coronary artery bypass grafting surgery of severe hemophilia A patient-the effect of heparin and protamine on factor VIII activity

Blood Coagulation and Fibrinolysis

Volumn 28, Issue 4, 2017, Pages 329-333

  Misgav, Mudi ^a   Mandelbaum, Tal ^b   Kassif, Yigal ^c   Berkenstadt, Haim ^b   Tamarin, Ilia ^a   Kenet, Gili ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b Department of Anesthesiology ^*  (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

cardiac surgery; hemophilia; heparin; protamine; thromboelastography

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; HEPARIN; HEPARIN LYASE; PROTAMINE; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 8; COAGULATING AGENT; HEPARIN ANTAGONIST;

ADULT; ARTICLE; BLOOD CLOTTING TIME; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; ELASTOGRAPH; HEMOPHILIA A; HEPARINIZATION; HUMAN; MIDDLE AGED; PRIORITY JOURNAL; THROMBOELASTOGRAPHY; DRUG EFFECTS; HEMOSTASIS; MALE; PERIOPERATIVE PERIOD; PROCEDURES;

ANTICOAGULANTS; COAGULANTS; CORONARY ARTERY BYPASS; FACTOR VIII; HEMOPHILIA A; HEMOSTASIS; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROTAMINES; THROMBELASTOGRAPHY;

EID: 84973360925     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000575     Document Type: Article

References (30)

1. Pipe SW, Valentino LA. Optimizing outcomes for patients with severe haemophilia A. Haemophilia 2007; 13 (Suppl 4):1-16.
2. Hermans C, De Moerloose P, Fischer K, Holstein K, Klamroth R, Lambert T, et al., European Haemophilia Therapy Standardisation Board. Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations. Haemophilia 2011; 17:383-392.
3. Franchini M, Mannucci PM. Hemophilia A in the third millennium. Blood Rev 2013; 27:179-184; Review.
4. Rossi M, Jayaram R, Sayeed R. Do patients with haemophilia undergoing cardiac surgery have good surgical outcomes? Interact Cardiovasc Thorac Surg 2011; 13:320-331.
5. Ferraris VA, Boral LI, Cohen AJ, Smyth SS, White GC 2nd. Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B. Cardiol Rev 2015; 23:53-68.
6. Dolan G, Cruz JA, Steinhagen-Thiessen E, Kessler C, Haaning J, Lemm G, et al. Advances in hemophilia care: report of two symposia at the Hemophilia 2010 World Congress. Adv Ther (Suppl 1):2012; 1-16.
7. Tuinenburg A, Damen SA, Ypma PF, Mauser-Bunschoten EP, Voskuil M, Schutgens RE, et al. Cardiac catheterization and intervention in haemophilia patients: prospective evaluation of the 2009 institutional guideline. Haemophilia 2013; 19:370-377.
8. Tang M, Wierup P, Terp K, Ingerslev J, Sørensen B. Cardiac surgery in patients with haemophilia. Haemophilia 2009; 15:101-107.
9. MaCkinlay N, Taper J, Renisson F, Rickard K. Cardiac surgery and catheterization in patients with haemophilia. Haemophilia 2000; 6:84-88.
10. Pesaro AE, Gaz MV, Karbstein R, Perin M, Serrano CV, Damico E. Coronary artery bypass surgery, angioplasty and long term antiplatelet treatment in a type B hemophilia patient. Clinics 2009; 64:822-823.
11. Nahas C, Jones JW, Beall AC Jr, Lafuente J, Irani M. Myocardial revascularization in a hemophiliac. Cardiovasc Surg 1996; 4:557-558.
12. Grandmougin D, Delolme MC, Reynaud J, Barral X. Off-pump myocardial revascularization in a diabetic patient with severe hemophilia B and impaired left ventricular function: hematological and operative strategies. J Card Surg 2005; 20:366-369.
13. Patel AJ, Liu H-H, Lager RA, Malkovska V, Zhang B. Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1. Haemophilia 2013; 19:607-610.
14. Frattini F, Bonfanti C, Piccoli P, Camurri N, Mantovani P, Terenziani I, et al. Triple coronary artery bypass graft surgery in a patient with factor VII deficiency: A case report. Haemophilia 2013; 19:e256-e269.
15. Gallinaro L, Casonato A, Vianello F, Fadin M, Cella G. Uneventful coronary artery bypass surgery without prophylactic replacement therapy in a patient with a novel heterozygous FVII gene deletion. Haemophilia 2009; 15:1159-1179.
16. Stine KC, Becton DL. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A. Haemophilia 2006; 12:435-436.
17. Sprunck A, Maechel AL, Levy F, Faradji A, Steib A. Off-pump myocardial revascularization in a patient with haemophilia A: A case report and operative strategies. Haemophilia 2012; 18:e20-e22.
18. Barillari G, Pasca S, Erice F, Livi U. Successful double bypass in a patient with severe hemophilia A: A case report. J Thromb Thrombolysis 2012; 33:193-196.
19. Holub DA, Norman JC, Cooley DA. Successful aortocoronary bypass surgery in a patient with classical hemophilia A. Cardiovasc Dis 1978; 5:229-234.
20. Lison S, Spannagl M, Dietrich W, Working Group of Perioperative Hemostasis. Hemophilia A in cardiac operations: A model of reduced thrombin generation. Ann Thorac Surg 2011; 91:1606-1608.
21. Ak K, Isbir CS, Tetik S, Atalan N, Tekeli A, Aljodi M, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: A prospective randomized study. J Card Surg 2009; 24:404-410.
22. Petricevic M, Biocina B, Milicic D, Svetina L, Boban M, Leki A, et al. Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: Analysis from the clinical trial (NCT01281397). J Cardiothorac Surg 2014; 17:129.
23. Chitlur M, Rivard GE, Lillicrap D, Mann K, Shima M, Young G, Factor VIII, Factor IX, and Rare Coagulation Disorders Subcommittee of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 2014; 12:103-106.
24. Fogarty PF, Mancuso ME, Kasthuri R, Bidlingmaier C, Chitlur M, Gomez K, et al., The Global Emerging HEmophilia Panel (GEHEP). Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey. Haemophilia 2015; 21:589-597.
25. Bhave P, McGiffin D, Shaw J, Walsh M, McCarthy P, Tran H, Davis AK. A guide to performing cardiac surgery in patients with hereditary bleeding disorders. J Card Surg 2015; 30:61-69.
26. Galeone A, Rotunno C, Guida P, Assunta B, Rubino G, Schinosa LD, Paparella D. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27:853-858.
27. National Institute for Healthcare and Excellence (NICE). Detecting, managing and monitoring haemostasis: viscoelastometric point of care testing (ROTEM, TEG and Sonoclot systems). 2014; http://guidance.nice.org.uk/DG13.
28. Ti LK, Cheong KF, Chen FG. Prediction of excessive bleeding after coronary artery bypass graft surgery: The influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth 2002; 16:545-550.
29. Bolliger D, Szlam F, Azran M, Koyama K, Levy JH, Molinaro RJ, Tanaka KA. The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations. Anesth Analg 2010; 111:601-608.
30. Barstad RM, Stephens RW, Hamers MJ, Sakariassen KS. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity. Thromb Haemost 2000; 83:334-337.